Astrana Health (NASDAQ:ASTH) Hits New 12-Month High – Here’s What Happened

Astrana Health, Inc. (NASDAQ:ASTH) shares hit a new 52-week high during trading on Wednesday . The company traded as high as $39.92 and last traded at $39.7950, with a volume of 333012 shares changing hands. The stock had previously closed at $39.01.

Analysts Set New Price Targets

A number of brokerages have recently commented on ASTH. BTIG Research increased their price target on Astrana Health from $40.00 to $50.00 and gave the company a “buy” rating in a research note on Friday, May 8th. Needham & Company LLC increased their price target on Astrana Health from $30.00 to $41.00 and gave the company a “buy” rating in a research note on Friday, May 8th. Barclays increased their price target on Astrana Health from $26.00 to $37.00 and gave the company an “equal weight” rating in a research note on Monday. Robert W. Baird set a $45.00 price target on Astrana Health in a research note on Friday, May 8th. Finally, Zacks Research upgraded Astrana Health from a “strong sell” rating to a “hold” rating in a research note on Wednesday, March 11th. Six investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to data from MarketBeat, Astrana Health currently has an average rating of “Moderate Buy” and a consensus target price of $41.86.

Astrana Health Stock Performance

The firm has a market capitalization of $2.22 billion, a P/E ratio of 65.18 and a beta of 0.98. The company has a current ratio of 1.35, a quick ratio of 1.40 and a debt-to-equity ratio of 1.20. The company has a 50-day moving average of $28.49 and a 200-day moving average of $25.79.

Astrana Health (NASDAQ:ASTH) last announced its earnings results on Thursday, May 7th. The company reported $0.74 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.29 by $0.45. The business had revenue of $965.10 million during the quarter, compared to analyst estimates of $949.21 million. Astrana Health had a return on equity of 9.22% and a net margin of 0.86%.Astrana Health’s revenue for the quarter was up 55.6% compared to the same quarter last year. During the same period last year, the company earned $0.42 EPS. On average, equities analysts anticipate that Astrana Health, Inc. will post 1.43 earnings per share for the current fiscal year.

Institutional Trading of Astrana Health

Large investors have recently bought and sold shares of the business. Signaturefd LLC grew its holdings in Astrana Health by 57.9% during the 4th quarter. Signaturefd LLC now owns 1,058 shares of the company’s stock worth $26,000 after acquiring an additional 388 shares during the period. GAMMA Investing LLC grew its holdings in Astrana Health by 144.7% during the 4th quarter. GAMMA Investing LLC now owns 1,473 shares of the company’s stock worth $37,000 after acquiring an additional 871 shares during the period. Strs Ohio acquired a new stake in Astrana Health during the 4th quarter worth about $40,000. Covestor Ltd grew its holdings in Astrana Health by 210.6% during the 3rd quarter. Covestor Ltd now owns 3,233 shares of the company’s stock worth $92,000 after acquiring an additional 2,192 shares during the period. Finally, Tower Research Capital LLC TRC grew its holdings in Astrana Health by 323.3% during the 2nd quarter. Tower Research Capital LLC TRC now owns 4,605 shares of the company’s stock worth $115,000 after acquiring an additional 3,517 shares during the period. 52.77% of the stock is currently owned by institutional investors and hedge funds.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.